2024 Year In Review | Page 3

1 Letter from the CEO

3

Year One of the New Biomarker : A Drug Pipeline Primed for Results

15

Advancing Better Treatments for All Stages of Parkinson ’ s

31

Our Community Drives Our Momentum

39

Together , We Look Ahead to a Cure